US965861A
(en)
|
1909-01-02 |
1910-08-02 |
Louis Berwanger |
Trap for sewer vent-pipes.
|
US2618708A
(en)
|
1942-08-06 |
1952-11-18 |
Automatic Elect Lab |
Telephone system with main and secondary register
|
US2884126A
(en)
*
|
1955-11-18 |
1959-04-28 |
Minnesota Mining & Mfg |
Pressure-sensitive adhesive sheet material
|
CA677797A
(en)
|
1955-11-18 |
1964-01-14 |
Minnesota Mining And Manufacturing Company |
Sheet material having a pressure-sensitive adhesive coating of acrylate ester copolymer
|
US3900610A
(en)
|
1973-04-09 |
1975-08-19 |
Monsanto Co |
Process of making a pressure sensitive adhesive article
|
US3886126A
(en)
*
|
1973-04-09 |
1975-05-27 |
Monsanto Co |
Solutions of pressure-sensitive resin solutions with improved viscosity and flow
|
US4053604A
(en)
|
1975-11-26 |
1977-10-11 |
Ayerst, Mckenna & Harrison Limited |
Method for improving anesthesia and compositions therefor
|
GB2079194B
(en)
|
1980-07-09 |
1983-08-03 |
Westering Insulation Systems L |
Coil shaping apparatus
|
US4508715A
(en)
*
|
1981-07-01 |
1985-04-02 |
University Of Georgia Research Foundation, Inc. |
Antagonism of central nervous system drugs by the administration of 4-aminopyridine alone or in combination with other drugs
|
US4486423A
(en)
|
1983-04-21 |
1984-12-04 |
Janssen Pharmaceutica Inc. |
Stable fentanyl composition
|
US4599342A
(en)
|
1984-01-16 |
1986-07-08 |
The Procter & Gamble Company |
Pharmaceutical products providing enhanced analgesia
|
US5288498A
(en)
*
|
1985-05-01 |
1994-02-22 |
University Of Utah Research Foundation |
Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
|
US4588580B2
(en)
|
1984-07-23 |
1999-02-16 |
Alaz Corp |
Transdermal administration of fentanyl and device therefor
|
US4626539A
(en)
|
1984-08-10 |
1986-12-02 |
E. I. Dupont De Nemours And Company |
Trandermal delivery of opioids
|
DE3586707T2
(de)
|
1984-10-05 |
1993-02-11 |
Hercon Lab |
System zur transdermalen applikation eines arzneimittels.
|
US5785989A
(en)
|
1985-05-01 |
1998-07-28 |
University Utah Research Foundation |
Compositions and methods of manufacturing of oral dissolvable medicaments
|
US5122127A
(en)
*
|
1985-05-01 |
1992-06-16 |
University Of Utah |
Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
|
US5288497A
(en)
*
|
1985-05-01 |
1994-02-22 |
The University Of Utah |
Compositions of oral dissolvable medicaments
|
US4645502A
(en)
*
|
1985-05-03 |
1987-02-24 |
Alza Corporation |
Transdermal delivery of highly ionized fat insoluble drugs
|
US5560922A
(en)
|
1986-05-30 |
1996-10-01 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
|
US5820876A
(en)
|
1986-08-28 |
1998-10-13 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system
|
US4938759A
(en)
|
1986-09-02 |
1990-07-03 |
Alza Corporation |
Transdermal delivery device having a rate controlling adhesive
|
US4906463A
(en)
*
|
1986-12-22 |
1990-03-06 |
Cygnus Research Corporation |
Transdermal drug-delivery composition
|
AU601528B2
(en)
|
1986-12-22 |
1990-09-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
|
AU607172B2
(en)
*
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
US4911707A
(en)
*
|
1987-02-13 |
1990-03-27 |
Ciba-Geigy Corporation |
Monolithic user-activated transdermal therapeutic system
|
US4822802A
(en)
*
|
1987-02-24 |
1989-04-18 |
Alza Corporation |
Method of fentanly administration for postoperative pain relief
|
US5080646A
(en)
*
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5000886A
(en)
*
|
1987-05-26 |
1991-03-19 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules and process of making the same
|
US4879297A
(en)
|
1987-06-01 |
1989-11-07 |
Warner-Lambert Company |
Fatty acids and their small chain esters as penetration enhancers in aqueous systems
|
DE3729299A1
(de)
|
1987-09-02 |
1989-03-23 |
Beiersdorf Ag |
Transdermales therapeutisches system
|
US4915950A
(en)
*
|
1988-02-12 |
1990-04-10 |
Cygnus Research Corporation |
Printed transdermal drug delivery device
|
US4906475A
(en)
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
GB8804164D0
(en)
|
1988-02-23 |
1988-03-23 |
Tucker J M |
Bandage for administering physiologically active compound
|
US5656286A
(en)
*
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5474783A
(en)
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US4927408A
(en)
*
|
1988-10-03 |
1990-05-22 |
Alza Corporation |
Electrotransport transdermal system
|
US5236714A
(en)
|
1988-11-01 |
1993-08-17 |
Alza Corporation |
Abusable substance dosage form having reduced abuse potential
|
JP2693212B2
(ja)
*
|
1989-03-28 |
1997-12-24 |
日東電工株式会社 |
疾患治療用テープ製剤
|
GB8909891D0
(en)
*
|
1989-04-28 |
1989-06-14 |
Riker Laboratories Inc |
Device
|
DE3924393A1
(de)
|
1989-07-24 |
1991-01-31 |
Roehm Gmbh |
Wasserloeslicher druckempfindlicher hauthaftkleber, dessen verwendung und damit ausgeruestete mittel
|
US5405997A
(en)
*
|
1989-07-25 |
1995-04-11 |
The Upjohn Company |
Antiarrhythmic methanesulfonamides
|
US5187849A
(en)
*
|
1989-08-24 |
1993-02-23 |
Nitto Kogyo Co., Ltd. |
Fixing roll for electrophotography having an outer fluoro-resin coating
|
AU644815B2
(en)
*
|
1989-09-08 |
1993-12-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
Solid matrix system for transdermal drug delivery
|
US5462744A
(en)
|
1989-12-01 |
1995-10-31 |
Boehringer Ingelheim Kg |
Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
|
US5167616A
(en)
|
1989-12-14 |
1992-12-01 |
Alza Corporation |
Iontophoretic delivery method
|
ATE100385T1
(de)
*
|
1989-12-21 |
1994-02-15 |
Von Roll Seilbahnen Ag |
Seilfoerderanlage.
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5120532A
(en)
*
|
1990-04-06 |
1992-06-09 |
The Procter & Gamble Company |
Hair styling shampoos
|
US5279594A
(en)
*
|
1990-05-23 |
1994-01-18 |
Jackson Richard R |
Intubation devices with local anesthetic effect for medical use
|
US5069909A
(en)
|
1990-06-20 |
1991-12-03 |
Cygnus Therapeutic Systems |
Transdermal administration of buprenorphine
|
US5180716A
(en)
*
|
1990-08-01 |
1993-01-19 |
The Regents Of The University Of California |
Cyclodextrin complexes for neuraxial administration of drugs
|
WO1992016236A1
(en)
*
|
1991-03-19 |
1992-10-01 |
Rajadhyaksha Vithal J |
Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
|
US5416191A
(en)
*
|
1991-04-01 |
1995-05-16 |
Cortech, Inc. |
Bradykinin antagonists
|
AU1537292A
(en)
|
1991-04-16 |
1992-11-17 |
Nippon Shinyaku Co. Ltd. |
Method of manufacturing solid dispersion
|
US5203768A
(en)
*
|
1991-07-24 |
1993-04-20 |
Alza Corporation |
Transdermal delivery device
|
US5804213A
(en)
|
1991-10-09 |
1998-09-08 |
Lectec Corporation |
Biologically active aqueous gel wound dressing
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5260066A
(en)
|
1992-01-16 |
1993-11-09 |
Srchem Incorporated |
Cryogel bandage containing therapeutic agent
|
US20020052007A1
(en)
*
|
1992-02-03 |
2002-05-02 |
Chang Kwen Jen |
Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
|
IL101387A
(en)
|
1992-03-26 |
1999-11-30 |
Pharmos Ltd |
Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
|
US5382451A
(en)
|
1992-04-06 |
1995-01-17 |
Minnesota Mining And Manufacturing |
Method for coating adhesive polymers
|
DE4223004A1
(de)
|
1992-07-13 |
1994-01-20 |
Liedtke Pharmed Gmbh |
Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie
|
DE69332378T2
(de)
|
1992-07-23 |
2003-07-10 |
Hisamitsu Pharmaceutical Co., Inc. |
Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung
|
US20010006967A1
(en)
|
1992-09-21 |
2001-07-05 |
Stanley M. Crain |
Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonists
|
US5543407A
(en)
|
1992-09-30 |
1996-08-06 |
Ningbo Institute Of Microcirculation And Henbane |
Preparation and application of scopolamine and chlorpromazine as a drug-withdrawal agent
|
US5883115A
(en)
|
1992-11-09 |
1999-03-16 |
Pharmetrix Division Technical Chemicals & Products, Inc. |
Transdermal delivery of the eutomer of a chiral drug
|
KR100212961B1
(ko)
|
1992-12-31 |
1999-08-02 |
조민호 |
경피투여시스템
|
US5465151A
(en)
|
1993-01-21 |
1995-11-07 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Sensors employing interference of electromagnetic waves passing through waveguides having functionalized surfaces
|
US5507277A
(en)
*
|
1993-01-29 |
1996-04-16 |
Aradigm Corporation |
Lockout device for controlled release of drug from patient-activateddispenser
|
US5569450A
(en)
|
1993-03-17 |
1996-10-29 |
Minnesota Mining And Manufacturing Company |
Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
|
DE4310012A1
(de)
*
|
1993-03-27 |
1994-09-29 |
Roehm Gmbh |
Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
|
US5891842A
(en)
*
|
1993-04-09 |
1999-04-06 |
Trustees Of Tufts College |
Methodology for eliciting an analgesic response in a living subject
|
AU678237B2
(en)
|
1993-04-20 |
1997-05-22 |
Hexal Pharma Gmbh |
Active substance-containing plaster
|
US5762952A
(en)
*
|
1993-04-27 |
1998-06-09 |
Hercon Laboratories Corporation |
Transdermal delivery of active drugs
|
US5497763A
(en)
*
|
1993-05-21 |
1996-03-12 |
Aradigm Corporation |
Disposable package for intrapulmonary delivery of aerosolized formulations
|
US5554381A
(en)
|
1993-08-09 |
1996-09-10 |
Cygnus, Inc. |
Low flux matrix system for delivering potent drugs transdermally
|
US5885564A
(en)
*
|
1993-08-13 |
1999-03-23 |
Lancaster Group Gmbh |
Functional oxygenated composition containing phospholipids and fluorocarbon
|
US5387466A
(en)
|
1993-08-31 |
1995-02-07 |
Adhesives Research, Inc. |
Water absorbent pressure sensitive adhesive
|
GB2283557B
(en)
|
1993-11-05 |
1998-03-25 |
Luk Lamellen & Kupplungsbau |
Rotary vibration damper
|
US5608035A
(en)
*
|
1994-02-02 |
1997-03-04 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-1 receptor
|
US5635204A
(en)
*
|
1994-03-04 |
1997-06-03 |
Montefiore Medical Center |
Method for transdermal induction of anesthesia, analgesia or sedation
|
US5451408A
(en)
|
1994-03-23 |
1995-09-19 |
Liposome Pain Management, Ltd. |
Pain management with liposome-encapsulated analgesic drugs
|
AU2286995A
(en)
*
|
1994-04-08 |
1995-10-30 |
Alza Corporation |
Electrotransport system with ion exchange competitive ion capture
|
US5871460A
(en)
*
|
1994-04-08 |
1999-02-16 |
Alza Corporation |
Electrotransport system with ion exchange material providing enhanced drug delivery
|
US5769778A
(en)
*
|
1994-04-22 |
1998-06-23 |
Somatics, Inc. |
Medical magnetic non-convulsive stimulation therapy
|
JP3911290B2
(ja)
*
|
1994-05-13 |
2007-05-09 |
アラダイム コーポレーション |
エアゾールを含む麻酔用処方
|
US5589480A
(en)
|
1994-08-17 |
1996-12-31 |
Elkhoury; George F. |
Topical application of opioid analgesic drugs such as morphine
|
US5849769A
(en)
|
1994-08-24 |
1998-12-15 |
Medivir Ab |
N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection
|
DE69517816T2
(de)
|
1994-09-14 |
2000-12-28 |
Minnesota Mining & Mfg |
Matrix für transdermale wirkstofffreisetzung
|
DE4438989C2
(de)
|
1994-09-16 |
1999-02-25 |
Lohmann Therapie Syst Lts |
Scopolaminpflaster
|
US5714162A
(en)
*
|
1994-09-16 |
1998-02-03 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Scopolamine patch
|
US7027859B1
(en)
|
1994-09-26 |
2006-04-11 |
Alza Corporation |
Electrotransport delivery device having improved safety and reduced abuse potential
|
US5522385A
(en)
|
1994-09-27 |
1996-06-04 |
Aradigm Corporation |
Dynamic particle size control for aerosolized drug delivery
|
CA2201358C
(en)
|
1994-09-30 |
2004-06-08 |
Jurgen Regenold |
Pharmaceutical composition
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
DE4440337A1
(de)
*
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
US5861439A
(en)
*
|
1994-11-14 |
1999-01-19 |
Alza Corporation |
Method for enhanced electrotransport agent delivery
|
US5697896A
(en)
|
1994-12-08 |
1997-12-16 |
Alza Corporation |
Electrotransport delivery device
|
JPH10510540A
(ja)
*
|
1994-12-12 |
1998-10-13 |
オメロス メディカル システムズ,インコーポレーテッド |
灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
|
GB9426102D0
(en)
*
|
1994-12-23 |
1995-02-22 |
Merck Sharp & Dohme |
Pharmacuetical compositions
|
US6299901B1
(en)
|
1995-01-13 |
2001-10-09 |
Somerset Pharmaceuticals, Inc. |
Methods and pharmaceutical compositions employing desmethylselegiline
|
US5562607A
(en)
|
1995-01-18 |
1996-10-08 |
Alza Corporation |
Electrotransport device having reusable controller power saver
|
DE69603577T2
(de)
|
1995-02-10 |
1999-11-25 |
Medtronic, Inc. |
Verfahren und vorrichtung zur verabreichung von analgetika
|
US5558879A
(en)
|
1995-04-28 |
1996-09-24 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water soluble drugs in which a passageway is formed in situ
|
IE960312A1
(en)
|
1995-06-02 |
1996-12-11 |
Alza Corp |
An electrotransport delivery device with voltage boosting¹circuit
|
US6881208B1
(en)
*
|
1995-06-05 |
2005-04-19 |
Joseph B. Phipps |
Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6425892B2
(en)
|
1995-06-05 |
2002-07-30 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
IE960375A1
(en)
|
1995-06-05 |
1996-12-11 |
Alza Corp |
Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
|
US5693335A
(en)
|
1995-06-07 |
1997-12-02 |
Cygnus, Inc. |
Skin permeation enhancer composition for use with sex steroids
|
IL122499A
(en)
|
1995-06-07 |
2003-02-12 |
Oneil Alexander G B |
Patient controlled drug delivery device
|
US6093419A
(en)
|
1995-06-07 |
2000-07-25 |
Lectec Corporation |
Compliance verification method and device in compulsory drug administration
|
US5780050A
(en)
*
|
1995-07-20 |
1998-07-14 |
Theratech, Inc. |
Drug delivery compositions for improved stability of steroids
|
DE19527925C2
(de)
*
|
1995-07-29 |
1997-07-03 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht
|
AUPN603895A0
(en)
|
1995-10-19 |
1995-11-09 |
University Of Queensland, The |
Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids
|
GB9522403D0
(en)
|
1995-11-01 |
1996-01-03 |
Hoechst Roussel Ltd |
Intravaginal drug delivery device
|
AU730495B2
(en)
*
|
1995-11-13 |
2001-03-08 |
North West University |
Administration media for analgesic, antiinflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
|
US5998434A
(en)
|
1995-12-06 |
1999-12-07 |
Eli Lilly And Company |
Composition for treating pain
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
CA2250042A1
(en)
|
1996-03-25 |
1997-10-02 |
Eli Lilly And Company |
Treating pain using a synergistic combination of an atypical antipsychotic and a drug used in treatment of pain
|
US5861483A
(en)
|
1996-04-03 |
1999-01-19 |
Pro-Neuron, Inc. |
Inhibitor of stem cell proliferation and uses thereof
|
US5886164A
(en)
*
|
1996-04-15 |
1999-03-23 |
Zeneca Limited |
DNA encoding enzymes related to ethylene biosynthesis and ripening from banana
|
US6271240B1
(en)
|
1996-05-06 |
2001-08-07 |
David Lew Simon |
Methods for improved regulation of endogenous dopamine in prolonged treatment of opioid addicted individuals
|
GB9609779D0
(en)
*
|
1996-05-10 |
1996-07-17 |
Univ Bruxelles |
Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
|
TW411277B
(en)
*
|
1996-05-13 |
2000-11-11 |
Hisamitsu Pharmaceutical Co |
Percutaneous tape preparation containing fentanyl
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
US6718201B1
(en)
|
1996-06-07 |
2004-04-06 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
IL127956A0
(en)
|
1996-07-11 |
1999-11-30 |
Farmarc Nederland Bv |
Inclusion complex containing indole selective serotonin agonist
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
KR20000029784A
(ko)
*
|
1996-08-02 |
2000-05-25 |
나까도미 히로다카 |
경구제제용캡슐과경구캡슐제제
|
US5985317A
(en)
|
1996-09-06 |
1999-11-16 |
Theratech, Inc. |
Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
|
WO1998013085A1
(en)
|
1996-09-26 |
1998-04-02 |
Akzo Nobel N.V. |
Needle-less injector
|
AU4320997A
(en)
|
1996-09-26 |
1998-04-17 |
Hokuriku Seiyaku Co. Ltd |
Percutaneous preparations
|
AU5081298A
(en)
|
1996-10-15 |
1998-05-11 |
R. John Hurlbert |
Surgical method and composition therefor
|
US6650934B2
(en)
*
|
1996-12-17 |
2003-11-18 |
Alza Corp |
Polymeric foam reservoirs for an electrotransport delivery device
|
US6246904B1
(en)
|
1996-12-17 |
2001-06-12 |
Alza Corporation |
Electrotransport drug delivery reservoirs containing inert fillers
|
DE19653605C2
(de)
*
|
1996-12-20 |
2002-11-28 |
Roehm Gmbh |
Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
|
DE19653606A1
(de)
|
1996-12-20 |
1998-06-25 |
Roehm Gmbh |
Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
|
WO1998029736A1
(en)
*
|
1996-12-31 |
1998-07-09 |
Genometrix Incorporated |
Multiplexed molecular analysis apparatus and method
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
DE19706824C1
(de)
*
|
1997-02-21 |
1998-03-26 |
Lohmann Therapie Syst Lts |
Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
AUPO612397A0
(en)
|
1997-04-11 |
1997-05-08 |
University Of Queensland, The |
Novel diflunisal esters and related compounds
|
GB9707934D0
(en)
|
1997-04-18 |
1997-06-04 |
Danbiosyst Uk |
Improved delivery of drugs to mucosal surfaces
|
US5976547A
(en)
|
1997-04-22 |
1999-11-02 |
Niblick Pharmaceuticals, Inc. |
Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
|
US5919473A
(en)
|
1997-05-12 |
1999-07-06 |
Elkhoury; George F. |
Methods and devices for delivering opioid analgesics to wounds via a subdermal implant
|
US20020039594A1
(en)
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
ATE221770T1
(de)
*
|
1997-05-14 |
2002-08-15 |
Galen Chemicals Ltd |
Topische mittel
|
US5861149A
(en)
*
|
1997-06-04 |
1999-01-19 |
Polyheal Ltd. |
Methods for wound treatment
|
US6528271B1
(en)
*
|
1997-06-05 |
2003-03-04 |
Duke University |
Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
|
US20020128248A1
(en)
|
1997-06-20 |
2002-09-12 |
Metaphore Pharmaceuticals, Inc |
SODm therapy for prevention and/or treatment of inflammatory disease
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
GB9714650D0
(en)
|
1997-07-11 |
1997-09-17 |
Strakan Ltd |
Block copolymer
|
US6004577A
(en)
|
1997-08-12 |
1999-12-21 |
Murdock; Thomas O. |
Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
|
US5948433A
(en)
|
1997-08-21 |
1999-09-07 |
Bertek, Inc. |
Transdermal patch
|
DE69819748T2
(de)
*
|
1997-09-12 |
2004-09-30 |
Columbia Laboratories (Bermuda) Ltd. |
Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
|
RS49982B
(sr)
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
AU1302499A
(en)
*
|
1997-11-12 |
1999-05-31 |
Alza Corporation |
Buffered drug formulations for transdermal electrotransport delivery
|
US6039977A
(en)
*
|
1997-12-09 |
2000-03-21 |
Alza Corporation |
Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods
|
US6210705B1
(en)
*
|
1997-12-15 |
2001-04-03 |
Noven Pharmaceuticals, Nc. |
Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
ES2281940T3
(es)
*
|
1997-12-17 |
2007-10-01 |
Alza Corporation |
Iontoforesis con ajuste programado de la corriente electrica.
|
US6163720A
(en)
|
1997-12-18 |
2000-12-19 |
Alza Corporation |
Layered rate controlling membranes for use in an electrotransport device
|
US6267984B1
(en)
|
1997-12-22 |
2001-07-31 |
Alza Corporation |
Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
|
JP4215188B2
(ja)
*
|
1997-12-22 |
2009-01-28 |
インターシア セラピューティクス,インコーポレイティド |
薬剤供給を調節するデバイスのための速度調節膜
|
WO1999038564A1
(en)
*
|
1998-01-28 |
1999-08-05 |
Alza Corporation |
Electrochemically reactive cathodes for an electrotransport device
|
US6143278A
(en)
|
1998-02-23 |
2000-11-07 |
Elkhoury; George F. |
Topical application of opioid analgesic drugs such as morphine
|
WO1999045906A1
(en)
|
1998-03-09 |
1999-09-16 |
Trustees Of Tufts College |
Treatment of compulsive behaviours in man and animals
|
US6350470B1
(en)
*
|
1998-04-29 |
2002-02-26 |
Cima Labs Inc. |
Effervescent drug delivery system for oral administration
|
KR19980025307A
(ko)
*
|
1998-04-11 |
1998-07-06 |
조태임 |
진통효과를 갖는 약물의 경피흡수제제
|
JP4205778B2
(ja)
|
1998-04-17 |
2009-01-07 |
久光製薬株式会社 |
貼付製剤
|
DE19818955C2
(de)
*
|
1998-04-28 |
2000-06-29 |
Lohmann Therapie Syst Lts |
Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat
|
GB9810126D0
(pt)
|
1998-05-13 |
1998-07-08 |
Glaxo Group Ltd |
|
US6398481B2
(en)
|
1998-05-14 |
2002-06-04 |
Avision Inc. |
Printer collators for collating printed papers in more than one positions
|
EP1079807B1
(en)
*
|
1998-05-27 |
2006-09-13 |
Euro-Celtique S.A. |
Use of preparations for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract
|
EP1082056B1
(en)
*
|
1998-06-03 |
2007-11-14 |
Scott Laboratories, Inc. |
Apparatus for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
|
US6717030B2
(en)
|
1998-07-06 |
2004-04-06 |
The Regents Of The University Of California |
Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
|
US6946144B1
(en)
*
|
1998-07-08 |
2005-09-20 |
Oryxe |
Transdermal delivery system
|
BR9912827A
(pt)
*
|
1998-07-16 |
2001-05-02 |
Sloan Kettering Inst Cancer |
Composições tópicas compreendendo um analgésico opióide e um antagonista de nmda
|
AU5102799A
(en)
|
1998-07-16 |
2000-02-07 |
Memorial Sloan-Kettering Cancer Center |
Multiple splice variants of the mu-opioid receptor gene
|
CA2343100A1
(en)
|
1998-09-08 |
2000-05-04 |
Srinivasan Venkateshwaran |
Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
|
SE9803240D0
(sv)
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
US6955819B2
(en)
|
1998-09-29 |
2005-10-18 |
Zars, Inc. |
Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
|
US7001609B1
(en)
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
HUP0104383A3
(en)
*
|
1998-11-02 |
2002-12-28 |
Alza Corp Mountain View |
Electrotransport drug delivery device including a compatible antimicrobial agent
|
DE19850517B4
(de)
*
|
1998-11-03 |
2004-02-12 |
Lts Lohmann Therapie-Systeme Ag |
Verwendung eines wirkstoffhaltigen transdermalen therapeutischen Systems in einer Kombinationsbehandlung mit und ohne Ultraschall
|
WO2000031123A2
(en)
|
1998-11-19 |
2000-06-02 |
Elan Corporation, Plc |
Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
EP1133571B1
(en)
|
1998-11-23 |
2006-06-28 |
Proteome Sciences, Inc. |
Methods and compositions for pain management
|
US6849263B2
(en)
*
|
1998-12-21 |
2005-02-01 |
Generex Pharmaceutical Incorporated |
Pharmaceutical compositions for buccal delivery of pain relief medications
|
US6275728B1
(en)
|
1998-12-22 |
2001-08-14 |
Alza Corporation |
Thin polymer film drug reservoirs
|
US6355657B1
(en)
*
|
1998-12-30 |
2002-03-12 |
Atrix Laboratories, Inc. |
System for percutaneous delivery of opioid analgesics
|
WO2000041538A2
(en)
|
1999-01-14 |
2000-07-20 |
Noven Pharmaceuticals, Inc. |
Dermal compositions
|
DE19901687B4
(de)
*
|
1999-01-18 |
2006-06-01 |
Grünenthal GmbH |
Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
|
PE20001396A1
(es)
|
1999-01-18 |
2000-12-23 |
Gruenenthal Chemie |
Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
|
US6753337B2
(en)
|
1999-01-27 |
2004-06-22 |
Wyeth Holdings Corporation |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
WO2000047203A1
(en)
|
1999-02-12 |
2000-08-17 |
Mqs, Inc. |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
CH693625A5
(it)
*
|
1999-02-18 |
2003-11-28 |
Inpharma Sa |
Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi.
|
US6680071B1
(en)
|
1999-03-03 |
2004-01-20 |
R. P. Scherer Technologies, Inc. |
Opioid agonist in a fast dispersing dosage form
|
US6835194B2
(en)
*
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
DE19912477A1
(de)
|
1999-03-19 |
2000-09-28 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System und Verfahren zu seiner Herstellung
|
ES2244422T3
(es)
|
1999-04-01 |
2005-12-16 |
Alza Corporation |
Dispositivos para la administracion transdermica de farmacos que comprenden un deposito de poliuretano para farmacos.
|
US6383471B1
(en)
*
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
WO2000061120A1
(fr)
*
|
1999-04-13 |
2000-10-19 |
Hisamitsu Pharmaceutical Co., Inc. |
Préparations destinées à être absorbées par voie percutanée
|
US6319510B1
(en)
|
1999-04-20 |
2001-11-20 |
Alayne Yates |
Gum pad for delivery of medication to mucosal tissues
|
DE19918106A1
(de)
|
1999-04-22 |
2000-10-26 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
|
US7186260B2
(en)
|
1999-04-29 |
2007-03-06 |
Hyson Morton I |
Medicated wrap
|
DE19923427A1
(de)
|
1999-05-21 |
2000-11-23 |
Lohmann Therapie Syst Lts |
Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
DE19925613A1
(de)
*
|
1999-06-04 |
2000-12-07 |
Lohmann Therapie Syst Lts |
Verbundlaminat und Verfahren zu seiner Herstellung
|
AU5325000A
(en)
|
1999-06-05 |
2000-12-28 |
David Houze |
Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
DE19938823A1
(de)
|
1999-08-19 |
2001-02-22 |
Boehringer Ingelheim Pharma |
Medikamentöse Behandlung des Restless Leg Syndroms
|
ATE279186T1
(de)
|
1999-08-31 |
2004-10-15 |
Gruenenthal Gmbh |
Retardierte darreichungsform enthaltend tramadolsaccharinat
|
EP1217975A1
(en)
|
1999-09-08 |
2002-07-03 |
Watson Pharmaceuticals, Inc. |
Using quaternary ammonium salts for transdermal drug delivery
|
US6420364B1
(en)
*
|
1999-09-13 |
2002-07-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compound useful as reversible inhibitors of cysteine proteases
|
US6528086B2
(en)
*
|
1999-09-28 |
2003-03-04 |
Zars, Inc. |
Methods and apparatus for drug delivery involving phase changing formulations
|
US6451806B2
(en)
|
1999-09-29 |
2002-09-17 |
Adolor Corporation |
Methods and compositions involving opioids and antagonists thereof
|
US20020147197A1
(en)
|
1999-10-08 |
2002-10-10 |
Newman Michael J. |
Methods and compositions for enhancing pharmaceutical treatments
|
KR20010036685A
(ko)
*
|
1999-10-11 |
2001-05-07 |
김윤 |
펜타닐을 함유하는 매트릭스형 경피투여제
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
US20040131665A1
(en)
|
1999-10-22 |
2004-07-08 |
Wepfer Scott T. |
Topical anesthetic formulation
|
US6264981B1
(en)
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
JP2003515588A
(ja)
|
1999-12-06 |
2003-05-07 |
マリンクロッド・インコーポレイテッド |
アルフェンタニル、スフェンタニルおよびレミフェンタニルの新合成法
|
US6716895B1
(en)
*
|
1999-12-15 |
2004-04-06 |
C.R. Bard, Inc. |
Polymer compositions containing colloids of silver salts
|
US6562368B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
|
GB9930071D0
(en)
|
1999-12-20 |
2000-02-09 |
Glaxo Group Ltd |
Medicaments
|
EP1242421A1
(en)
|
1999-12-22 |
2002-09-25 |
Ortho-McNeil Pharmaceutical, Inc. |
4-[aryl(8-azabicyclo[3.2.1] octan-3-yl)] aminobenzoic acid derivatives
|
EP1138330A1
(en)
|
1999-12-23 |
2001-10-04 |
Warner-Lambert Company |
Combination of trimebutine with an opioid analgesic
|
ITMI992711A1
(it)
|
1999-12-27 |
2001-06-27 |
Novartis Ag |
Composti organici
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
US20010039343A1
(en)
|
2000-01-28 |
2001-11-08 |
Mulvihill Mark Joseph |
Process to intermediates for biologically active compounds
|
US6716449B2
(en)
*
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
US6471688B1
(en)
|
2000-02-15 |
2002-10-29 |
Microsolutions, Inc. |
Osmotic pump drug delivery systems and methods
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
WO2001064149A1
(en)
|
2000-02-29 |
2001-09-07 |
Jie Zhang |
Improved transdermal drug patch
|
US6261595B1
(en)
|
2000-02-29 |
2001-07-17 |
Zars, Inc. |
Transdermal drug patch with attached pocket for controlled heating device
|
JP4216502B2
(ja)
*
|
2000-03-24 |
2009-01-28 |
ファルマシア コーポレーション |
酸化窒素シンターゼ阻害剤として有用なアミジノ化合物
|
KR100393478B1
(ko)
|
2000-03-29 |
2003-08-06 |
주식회사종근당 |
자가유화 매트릭스형 경점막·경피흡수제제
|
US6872786B2
(en)
|
2000-04-10 |
2005-03-29 |
The Johns Hopkins University |
Molecularly imprinted polymeric sensor for the detection of explosives
|
US6682473B1
(en)
|
2000-04-14 |
2004-01-27 |
Solace Therapeutics, Inc. |
Devices and methods for attenuation of pressure waves in the body
|
US6761895B2
(en)
|
2000-04-17 |
2004-07-13 |
Yamanouchi Pharmaceutical Co., Ltd. |
Drug delivery system for averting pharmacokinetic drug interaction and method thereof
|
WO2001082914A2
(en)
*
|
2000-04-28 |
2001-11-08 |
Memorial Sloan-Kettering Cancer Center |
Topical anesthetic/opioid formulations and uses thereof
|
US7049326B2
(en)
|
2000-05-12 |
2006-05-23 |
The University Of Toledo |
Method and compositions for temporarily incapacitating subjects
|
KR100452972B1
(ko)
|
2000-05-16 |
2004-10-14 |
주식회사 삼양사 |
경피투여용 하이드로젤 조성물
|
DE10025949A1
(de)
|
2000-05-26 |
2001-11-29 |
Gruenenthal Gmbh |
Arzneimittel zur Bekämpfung von Atemdepression
|
DE10025948A1
(de)
|
2000-05-26 |
2001-11-29 |
Gruenenthal Gmbh |
Wirkstoffkombination
|
DE10025946A1
(de)
|
2000-05-26 |
2001-11-29 |
Gruenenthal Gmbh |
Wirkstoffkombination
|
AU2001274307A1
(en)
|
2000-06-22 |
2002-01-02 |
Pharmasol Ltd |
Pharmaceutical compositions
|
GB0015617D0
(en)
|
2000-06-26 |
2000-08-16 |
Vectura Ltd |
Improved preparations for dermal delivery of active substances
|
US20020019421A1
(en)
|
2000-07-05 |
2002-02-14 |
Roni Biberman |
Compositions and therapy for substance addiction
|
US20020038310A1
(en)
|
2000-07-17 |
2002-03-28 |
Reitberg Donald P. |
Single-patient drug trials used with accumulated database: genomic markers
|
DK1307194T4
(da)
*
|
2000-07-31 |
2011-07-18 |
Nycomed Danmark Aps |
Fentanylpræparat til nasal administration
|
AR030312A1
(es)
|
2000-08-03 |
2003-08-20 |
Antares Pharma Ipl Ag |
Composicion novedosa para la administracion transdermica y/o transmucosica de compuestos activos, que asegura adecuados niveles terapeuticos
|
US6528520B2
(en)
|
2000-08-15 |
2003-03-04 |
Cpd, Llc |
Method of treating the syndrome of coronary heart disease risk factors in humans
|
US20020045572A1
(en)
|
2000-08-15 |
2002-04-18 |
Cpd, Llc |
Method of treating the syndrome of type 2 diabetes in humans
|
US20020099013A1
(en)
|
2000-11-14 |
2002-07-25 |
Thomas Piccariello |
Active agent delivery systems and methods for protecting and administering active agents
|
AU2001290719B2
(en)
|
2000-09-11 |
2006-06-22 |
Alza Corporation |
Transdermal electrotransport device and method for manufacturing same
|
JP2004509222A
(ja)
*
|
2000-09-19 |
2004-03-25 |
ナショナル スターチ アンド ケミカル インベストメント ホールディング コーポレイション |
経皮薬物送達システムにおいて有用な非反応型接着剤
|
EP1326642A2
(en)
|
2000-09-29 |
2003-07-16 |
Board of Trustees operating Michigan State University |
Catecholamine pharmaceutical compositions and methods
|
US20020119187A1
(en)
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
GB0026137D0
(en)
|
2000-10-25 |
2000-12-13 |
Euro Celtique Sa |
Transdermal dosage form
|
EP1353909B1
(en)
|
2000-10-31 |
2005-04-06 |
Rensselaer Polytechnic Institute |
8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
|
US6682757B1
(en)
*
|
2000-11-16 |
2004-01-27 |
Euro-Celtique, S.A. |
Titratable dosage transdermal delivery system
|
ATE365536T1
(de)
|
2000-11-29 |
2007-07-15 |
Lyotropic Therapeutics Inc |
Lösungsmittelsysteme für pharmazeutische mittel
|
US20020106407A1
(en)
|
2000-12-11 |
2002-08-08 |
Dennis Coleman |
Method and apparatus for treating breakthrough pain
|
US6887876B2
(en)
|
2000-12-14 |
2005-05-03 |
Ortho-Mcneil Pharmaceutical, Inc. |
Benzamidine derivatives
|
US20050019381A1
(en)
|
2001-01-29 |
2005-01-27 |
Hans-Ulrich Petereit |
Binding agent which is stable in storage and used for pharmaceutical applications
|
GB0102902D0
(en)
|
2001-02-06 |
2001-03-21 |
Innovata Biomed Ltd |
Medicaments
|
US20020160043A1
(en)
|
2001-02-27 |
2002-10-31 |
Dennis Coleman |
Compositions and method of manufacture for oral dissolvable dosage forms
|
US20050176790A1
(en)
|
2001-02-28 |
2005-08-11 |
Johannes Bartholomaus |
Pharmaceutical salts
|
US7988991B2
(en)
*
|
2001-03-07 |
2011-08-02 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive patch
|
JP4850346B2
(ja)
|
2001-03-15 |
2012-01-11 |
救急薬品工業株式会社 |
粘膜貼付剤
|
US20050208117A1
(en)
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
EP1757280A1
(en)
|
2001-03-16 |
2007-02-28 |
ALZA Corporation |
Transdermal patch for administering sufentanyl
|
NZ528148A
(en)
|
2001-03-16 |
2006-02-24 |
Alza Corp |
Transdermal patch for administering fentanyl
|
US20020176841A1
(en)
|
2001-03-19 |
2002-11-28 |
Praecis Pharmaceuticals Inc. |
Pharmaceutical formulations for sustained release
|
WO2002076388A2
(en)
|
2001-03-23 |
2002-10-03 |
Albert Einstein College Of Medecine Of Yeshiva University |
Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
|
NZ528750A
(en)
|
2001-04-04 |
2005-10-28 |
Alza Corp |
Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition
|
US7112319B2
(en)
|
2001-04-06 |
2006-09-26 |
The Research Foundation Of The City University Of New York |
Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using microelectrodes with microvoltammetry
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
EP2266719B1
(en)
|
2001-04-23 |
2016-06-08 |
Euro-Celtique S.A. |
Disposal system for transdermal dosage form
|
ATE339234T1
(de)
|
2001-04-30 |
2006-10-15 |
Medtronic Inc |
Implantierbare medizinische vorrichtung und kissenelektrodensystem
|
EA200301204A1
(ru)
|
2001-04-30 |
2004-04-29 |
Тромсдорф ГмбХ унд Ко.КГ Арцнаймиттель |
Фармацевтически активные производные нуклеозида, способ их получения, их применение (варианты) и содержащая их фармацевтическая композиция, способ профилактики и/или лечения заболеваний и нарушений млекопитающих (варианты), комбинация лекарственных средств и ее применение (варианты)
|
CA2473969A1
(en)
|
2001-04-30 |
2002-11-07 |
Lumimove, Inc. |
Electroluminescent devices fabricated with encapsulated light emitting polymer particles
|
DK2062573T3
(da)
|
2001-05-01 |
2012-01-30 |
Euro Celtique Sa |
Misbrugsresistent opioid indeholdende transdermale systemer
|
AU2002303718B2
(en)
*
|
2001-05-11 |
2008-02-28 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant opioid dosage form
|
US20020187996A1
(en)
|
2001-05-14 |
2002-12-12 |
Dewey Stephen L. |
Prevention of addiction in pain management
|
EP1405067A2
(en)
|
2001-05-23 |
2004-04-07 |
University Of Florida |
Method and apparatus for detecting illicit substances
|
AU2002312230A1
(en)
|
2001-06-05 |
2002-12-16 |
Elan Pharma International Limited |
System and method for milling materials
|
US6982263B2
(en)
*
|
2001-06-08 |
2006-01-03 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Nitriles useful as reversible inhibitors of cysteine proteases
|
US6745944B2
(en)
|
2001-06-20 |
2004-06-08 |
Capital One Financial Corporation |
System and method for identifying applications loaded in a smart card
|
GB0117183D0
(en)
|
2001-07-13 |
2001-09-05 |
Rockwool Int |
Method and apparatus for growing plants
|
DE10141651B4
(de)
*
|
2001-08-24 |
2007-02-15 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
|
DE20221159U1
(de)
|
2001-08-24 |
2005-04-07 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
DE10141652B4
(de)
*
|
2001-08-24 |
2011-04-07 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
|
DE10141650C1
(de)
*
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
AUPR731901A0
(en)
*
|
2001-08-28 |
2001-09-20 |
Goodchild, Colin Stanley |
Method of treatment
|
US7973064B2
(en)
*
|
2001-11-27 |
2011-07-05 |
The Board Of Trustees Of The University Of Illinois |
Method and composition for potentiating an opiate analgesic
|
GB0130518D0
(en)
|
2001-12-21 |
2002-02-06 |
Univ Gent |
Pulsed bio-agent delivery systems based on degradable polymer solutions or hydrogels
|
US20030139396A1
(en)
|
2002-01-22 |
2003-07-24 |
Karen Gibson |
Method of treatment
|
GB0203276D0
(en)
*
|
2002-02-12 |
2002-03-27 |
Novartis Ag |
Organic compounds
|
US7666876B2
(en)
*
|
2002-03-19 |
2010-02-23 |
Vernalis (R&D) Limited |
Buprenorphine formulations for intranasal delivery
|
US20050186141A1
(en)
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
US20050181032A1
(en)
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
GB0218261D0
(en)
|
2002-08-06 |
2002-09-11 |
Charterhouse Therapeutics Ltd |
Improvements in pharmaceutically useful compounds
|
US6946150B2
(en)
*
|
2002-08-14 |
2005-09-20 |
Gw Pharma Limited |
Pharmaceutical formulation
|
US20040086551A1
(en)
|
2002-10-30 |
2004-05-06 |
Miller Kenneth J. |
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
|
US20050278195A1
(en)
|
2004-05-28 |
2005-12-15 |
Getz Harry L |
Method for scheduling viewing of a live medical procedure
|